GlassScriptPhysician profile
Wandra K Miles
NPI 1902968258
$5,889.39
in general payments reported to CMS, 2019-2025
7 companies · $2,287 in 2025
The $2,287 reported for 2025 was more than what 86% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $75.02 · 2021: $199 · 2022: $557 · 2023: $133 · 2024: $2,638 · 2025: $2,287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,555 · Food and Beverage: $2,503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,555.35 |
| Food and Beverage | $2,502.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $2,182.81 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Mentor Worldwide LLC | $1,592.93 | 2021-2025 | Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Medical Device Business Services, INC. | $895.39 | 2024 | |
| Sientra, INC. | $743.16 | 2020-2022 | |
| Motiva USA, LLC | $286.19 | 2024-2025 | |
| Abbvie INC. | $155.31 | 2024-2025 | |
| Allergan, INC. | $33.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wandra Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.